Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Dexmedetomidine × Thoracic × Clear all

Status

Sponsor Class

Study Type

Interventional 5 Observational 1

Sponsor

Cancer Type

Breast 2 Thoracic 1 Gastrointestinal 1

Conditions

Lung Neoplasms 1 Esophageal Neoplasms 1

Interventions

Blood Specimen Collection 52 Surveys and Questionnaires 30 Drug Therapy 26 Immunotherapy 24 Surgical Procedures, Operative 22 Carboplatin 22 Nivolumab 21 Immune Checkpoint Inhibitors 20 osimertinib 19 pembrolizumab 18 atezolizumab 17 Radiotherapy 16 Observation 16 Bevacizumab 15 Cisplatin 14 Afatinib 14 Specimen Handling 13 Gene Expression Profiling 13 Erlotinib Hydrochloride 13 Pemetrexed 12 Magnetic Resonance Spectroscopy 11 Ipilimumab 11 Immunohistochemistry 11 Biopsy 11 lorlatinib 10 durvalumab 10 alectinib 10 Paclitaxel 10 Bronchoscopy 10 Interviews as Topic 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00839605 2016-10-04

Dex-One-Lung

University of Missouri-Columbia

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡